Skip to main content
. 2014 Aug 5;7:61–75. doi: 10.4137/NMI.S17245

Table 4.

General biomarkers in the blood of Japanese male subjects.

REFERENCE VALUE WEEK 1
(DAY 5)
WEEK 2
(DAY 12)
WEEK 3
(DAY 19)
WEEK 4
(DAY 26)
Erythrocyte count, ×104/μL 430–570 542 ± 17 529 ± 18 531 ± 20 525 ± 18
Leukocyte count, μL 3300–9000 5040 ± 1146 5150 ± 1339 5120 ± 1155 5210 ± 1333
Hemoglobin, g/dL 13.5–17.5 16.3 ± 0.5 15.8 ± 0.4 15.7 ± 0.5 15.7 ± 0.3
Hematocrit, % 39.7–52.4 48.7 ± 2.0 47.6 ± 1.9 47.1 ± 1.9 47.4 ± 1.8
MCV, fL 85–102 90.0 ± 3.7 90.0 ± 3.4 88.8 ± 3.4 90.5 ± 3.7
MCH, pg 28.0–34.0 30.1 ± 1.0 30.0 ± 0.8 29.5 ± 0.9 29.9 ± 0.8
MCHC, % 30.2–35.1 33.5 ± 0.7 33.3 ± 0.7 33.3 ± 0.5 33.1 ± 0.7
AST, U/L 10–40 16.4 ± 4.6 20.0 ± 6.1 22.6 ± 5.3 21.1 ± 6.7
ALT, U/L 5–45 17.6 ± 6.0 21.9 ± 7.4 19.3 ± 8.4 21.9 ± 5.5
γ-GTP, U/L >80 21.6 ± 12.9 21.1 ± 13.0 21.8 ± 14.1 22.2 ± 14.4
HDL-Cho, mg/dL 40–70 50 ± 6 49 ± 8 48 ± 6 50 ± 8
Total-Cho, mg/dL 120–219 175 ± 31 169 ± 22 174 ± 22 180 ± 27
Triglyceride, mg/dL 30–149 96 ± 60 93 ± 58 55.4 ± 24.8 54.9 ± 17.3
Total lipid, mg/dL 400–800 513 ± 74 493 ± 44 543 ± 106 539 ± 91
Blood glucose, mg/dL 70–109 86 ± 5 85 ± 5 86 ± 5 86 ± 5
Total protein, mg/dL 6.7–8.3 7.9 ± 0.4 7.5 ± 0.3 7.5 ± 0.4 7.6 ± 0.4
Albumin, mg/dL 3.8–5.3 5.2 ± 0.2 5.1 ± 0.2 5.0 ± 0.2 5.0 ± 0.2
Albumin/Globurin 1.1–2.0 1.9 ± 0.3 2.1 ± 0.3 2.1 ± 0.2 2.0 ± 0.3
Creatinine, mg/dL 0.61–1.04 0.91 ± 0.06 0.85 ± 0.06 0.84 ± 0.08 0.85 ± 0.09
Uric acid, mg/dL >7.0 6.1 ± 1.1 6.0 ± 1.0 6.0 ± 1.1 5.9 ± 1.0
Homocysteine, nmol/mL 3.7–13.5 7.1 ± 0.8 7.1 ± 0.9 6.6 ± 0.8 6.5 ± 0.8
Total bilirubin, mg/dL 0.–1.1 1.1 ± 0.4 1.0 ± 0.3 0.9 ± 0.3 1.1 ± 0.3
PIVKA-II, μg/mL >1 >1 >1 >1 >1

Notes:

1

Values are means ± SD for the 10 subjects. Nonparametric Friedman test for repeated measures following Dunn’s post-test was used to analyze statistical differences; no significant differences were observed at all.

Abbreviations: MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration.